Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2018-05-31 History
Report ID 31394
Drug Identification Number 02362635
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 4.0G 0.5G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging size 10 VIALS
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-05-03
Estimated end date 2018-06-04
Actual end date 2018-05-30
Shortage status Resolved
Updated date 2018-05-31
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2018-05-31 English Compare
v14 2018-05-30 French Compare
v13 2018-05-30 English Compare
v12 2018-05-22 French Compare
v11 2018-05-22 English Compare
v10 2018-05-04 English Compare
v9 2018-05-03 French Compare
v8 2018-05-03 English Compare
v7 2018-01-23 French Compare
v6 2018-01-23 English Compare
v5 2017-12-01 French Compare
v4 2017-12-01 English Compare
v3 2017-12-01 English Compare
v2 2017-11-30 French Compare
v1 2017-11-30 English Compare

Showing 1 to 15 of 15